Don’t Miss the Latest
Life Science and Healthcare Information

When you subscribe to the d-Wise blog, you’ll get the latest
industry trends, news and tips right in your inbox!

No, thanks. I don‘t need to stay current.

Life Sciences News - Major research funders and international NGOs to implement WHO standards on reporting clinical trial results

Excerpt from ReliefWeb's Article "Major research funders and international NGOs to implement WHO standards on reporting clinical trial results" | May 23, 2017


18 MAY 2017 | GENEVA – Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed

In a joint statement, the Indian Council of Medical Research, the Norwegian Research Council, the UK Medical Research Council, Médecins Sans Frontières and Epicentre (its research arm), PATH, the Coalition for Epidemic Preparedness Innovations (CEPI), Institut Pasteur, the Bill & Melinda Gates Foundation, and the Wellcome Trust agreed to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly-available registry. They also agreed that all results would be disclosed within specified timeframes on the registry and/or by publication in a scientific journal.

Today, about 50% of clinical trials go unreported, according to several studies, often because the results are negative. These unreported trial results leave an incomplete and potentially misleading picture of the risks and benefits of vaccines, drugs and medical devices, and can lead to use of suboptimal or even harmful products.


“Research funders are making a strong statement that there will be no more excuses on why some clinical trials remain unreported long after they have completed,” said Dr Marie-Paule Kieny, Assistant Director-General for Health Systems and Innovation at WHO.

Read Article Now

d-Wise's Insight on ReliefWeb's Article

I applaud the range of organizations that are pushing to make clinical research more transparent. Over 50 percent of clinical trials still go unreported, leading to the perception that researchers and the commercial industry are 'hiding' bad results. 

In reality, this is probably not the case, but this perception leaves people thinking the worst. By stepping forward and tying funding to the requirements around disclosing clinical trial information, this forces researchers and pharma companies to share this information.

d-Wise fully supports and believes in the need for transparency, and has a taken the lead in the realm of patient privacy and data transparency. We work with a number of pharmaceutical companies in anonymizing clinical reports and de-identifying clinical data. 


About the Author

Leave a Comment